These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
320 related items for PubMed ID: 15656623
1. Mechanism of inactivation of inducible nitric oxide synthase by amidines. Irreversible enzyme inactivation without inactivator modification. Zhu Y, Nikolic D, Van Breemen RB, Silverman RB. J Am Chem Soc; 2005 Jan 26; 127(3):858-68. PubMed ID: 15656623 [Abstract] [Full Text] [Related]
2. Mechanistic studies of inactivation of inducible nitric oxide synthase by amidines. Tang W, Li H, Poulos TL, Silverman RB. Biochemistry; 2015 Apr 21; 54(15):2530-8. PubMed ID: 25811913 [Abstract] [Full Text] [Related]
3. Suppression of acute experimental colitis by a highly selective inducible nitric-oxide synthase inhibitor, N-[3-(aminomethyl)benzyl]acetamidine. Kankuri E, Vaali K, Knowles RG, Lähde M, Korpela R, Vapaatalo H, Moilanen E. J Pharmacol Exp Ther; 2001 Sep 21; 298(3):1128-32. PubMed ID: 11504810 [Abstract] [Full Text] [Related]
5. Selective inhibition of inducible nitric oxide synthase inhibits tumor growth in vivo: studies with 1400W, a novel inhibitor. Thomsen LL, Scott JM, Topley P, Knowles RG, Keerie AJ, Frend AJ. Cancer Res; 1997 Aug 01; 57(15):3300-4. PubMed ID: 9242464 [Abstract] [Full Text] [Related]
6. Mechanism of inducible nitric oxide synthase inactivation by aminoguanidine and L-N6-(1-iminoethyl)lysine. Bryk R, Wolff DJ. Biochemistry; 1998 Apr 07; 37(14):4844-52. PubMed ID: 9538001 [Abstract] [Full Text] [Related]
7. Structural requirements for human inducible nitric oxide synthase substrates and substrate analogue inhibitors. Grant SK, Green BG, Stiffey-Wilusz J, Durette PL, Shah SK, Kozarich JW. Biochemistry; 1998 Mar 24; 37(12):4174-80. PubMed ID: 9521739 [Abstract] [Full Text] [Related]
8. 1400W is a slow, tight binding, and highly selective inhibitor of inducible nitric-oxide synthase in vitro and in vivo. Garvey EP, Oplinger JA, Furfine ES, Kiff RJ, Laszlo F, Whittle BJ, Knowles RG. J Biol Chem; 1997 Feb 21; 272(8):4959-63. PubMed ID: 9030556 [Abstract] [Full Text] [Related]
9. Studies of neuronal nitric oxide synthase inactivation by diverse suicide inhibitors. Bryk R, Lubeskie A, Wolff DJ. Arch Biochem Biophys; 1999 Sep 15; 369(2):243-51. PubMed ID: 10486143 [Abstract] [Full Text] [Related]
10. Effects of an inducible nitric oxide synthase inhibitor on experimentally induced rat pulpitis. Kawanishi HN, Kawashima N, Suzuki N, Suda H, Takagi M. Eur J Oral Sci; 2004 Aug 15; 112(4):332-7. PubMed ID: 15279652 [Abstract] [Full Text] [Related]
11. Antisense knockdown of inducible nitric oxide synthase inhibits the relaxant effect of VIP in isolated smooth muscle cells of the mouse gastric fundus. Dick JM, Van Molle W, Libert C, Lefebvre RA. Br J Pharmacol; 2001 Sep 15; 134(2):425-33. PubMed ID: 11564662 [Abstract] [Full Text] [Related]
12. Differential effects of substrate-analogue inhibitors on nitric oxide synthase dimerization. Lee KS, Lee DK, Jeoung D, Lee H, Choe J, Ha KS, Won MH, Kwon YG, Kim YM. Biochem Biophys Res Commun; 2012 Feb 03; 418(1):49-55. PubMed ID: 22240022 [Abstract] [Full Text] [Related]
13. Nitric oxide synthase inhibitors 1400W and L-NIO inhibit angiogenesis pathway of colorectal cancer. Gao Y, Zhou S, Xu Y, Sheng S, Qian SY, Huo X. Nitric Oxide; 2019 Feb 01; 83():33-39. PubMed ID: 30590117 [Abstract] [Full Text] [Related]
14. Reperfusion injury is reduced in skeletal muscle by inhibition of inducible nitric oxide synthase. Zhang L, Looney CG, Qi WN, Chen LE, Seaber AV, Stamler JS, Urbaniak JR. J Appl Physiol (1985); 2003 Apr 01; 94(4):1473-8. PubMed ID: 12506043 [Abstract] [Full Text] [Related]
15. Systemic use of selective iNOS inhibitor 1400W or non-selective NOS inhibitor l-NAME differently affects systemic nitric oxide formation after oral Porphyromonas gingivalis inoculation in mice. Nemec A, Pavlica Z, Petelin M, Crossley DA, Sentjurc M, Jerin A, Erzen D, Zdovc I, Hitti T, Skaleric U. Arch Oral Biol; 2010 Jul 01; 55(7):509-14. PubMed ID: 20430367 [Abstract] [Full Text] [Related]
16. Differential effects of selective and non-selective inhibition of nitric oxide synthase on the expression and activity of cyclooxygenase-2 during gastric ulcer healing. Guo JS, Cho CH, Wang JY, Koo MW. Eur J Pharmacol; 2006 May 01; 536(3):301-8. PubMed ID: 16600210 [Abstract] [Full Text] [Related]
17. Inhibition of iNOS activity by 1400W decreases glutamate release and ameliorates stroke outcome after experimental ischemia. Pérez-Asensio FJ, Hurtado O, Burguete MC, Moro MA, Salom JB, Lizasoain I, Torregrosa G, Leza JC, Alborch E, Castillo J, Knowles RG, Lorenzo P. Neurobiol Dis; 2005 Mar 01; 18(2):375-84. PubMed ID: 15686966 [Abstract] [Full Text] [Related]
18. Actions of isoform-selective and non-selective nitric oxide synthase inhibitors on endotoxin-induced vascular leakage in rat colon. László F, Whittle BJ. Eur J Pharmacol; 1997 Sep 03; 334(1):99-102. PubMed ID: 9346334 [Abstract] [Full Text] [Related]
19. Addition of nitric oxide donor S-nitroso-N-acetylcysteine to selective iNOS inhibitor 1400W further improves contractile function in reperfused skeletal muscle. Barker JU, Qi WN, Cai Y, Urbaniak JR, Chen LE. Microsurgery; 2005 Sep 03; 25(4):338-45. PubMed ID: 15880470 [Abstract] [Full Text] [Related]
20. Inhibition of iNOS with 1400W improves contractile function and alters nos gene and protein expression in reperfused skeletal muscle. Patel P, Qi WN, Allen DM, Chen LE, Seaber AV, Stamler JS, Urbaniak JR. Microsurgery; 2004 Sep 03; 24(4):324-31. PubMed ID: 15274192 [Abstract] [Full Text] [Related] Page: [Next] [New Search]